2015
DOI: 10.1530/endoabs.37.ep740
|View full text |Cite
|
Sign up to set email alerts
|

Differentiated thyroid cancer in patients with prolactinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2018
2018
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…One reason for this could be that routine thyroid USG was not performed in these patients, and every patient with a neck USG due to any other reason, including suspicious findings during thyroid palpation, was included in this study. However, in two recent studies, an increased frequency of NTD was reported in prolactinoma patients (11,12), and two other studies demonstrated increased NTD frequency in patients with CD compared to the general population (14,15). Although NTD was more common in patients with acromegaly, dominant nodule size and distribution of single or multiple nodules were similar in all three groups.…”
Section: Discussionmentioning
confidence: 81%
See 3 more Smart Citations
“…One reason for this could be that routine thyroid USG was not performed in these patients, and every patient with a neck USG due to any other reason, including suspicious findings during thyroid palpation, was included in this study. However, in two recent studies, an increased frequency of NTD was reported in prolactinoma patients (11,12), and two other studies demonstrated increased NTD frequency in patients with CD compared to the general population (14,15). Although NTD was more common in patients with acromegaly, dominant nodule size and distribution of single or multiple nodules were similar in all three groups.…”
Section: Discussionmentioning
confidence: 81%
“…Screening for papillary thyroid carcinoma (PTC) is recommended in patients with acromegaly due to their higher risk of developing tumors, but not for prolactinoma and CD patients (2)(3)(4)(5)(6)(7)(8)(9)(17)(18)(19)(20)(21). We found only one study that evaluated the prevalence of PTC in prolactinomas (12) and one case report on the co-existence of CD and PTC (22). We detected a higher frequency of NTD in CD and prolactinoma patients in our clinical practice, along with a concurrent increase in PTC diagnosis.…”
Section: Introductionmentioning
confidence: 68%
See 2 more Smart Citations
“…4 had a mild increase of prolactin, which is not typically related to thyroid nodules [9][10][11] . Recent studies showed an increased risk of thyroid enlargement and nodularity in patients with prolactinoma or other neuroendocrine tumours, but not of thyroid cancer [9][10][11] . High prolactin values may be related to mammary cysts of different dimensions, but not to similar lesions of the thyroid 9-11 .…”
Section: Discussionmentioning
confidence: 99%